Preformed Line Products (PLPC) Financials

$133.67 +1.36 (+1.03%)

Closing price 04:00 PM Eastern

Extended Trading

$133.58 -0.09 (-0.07%)

As of 04:20 PM Eastern

Annual Income Statements for Preformed Line Products

This table shows Preformed Line Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	54	63	37
Consolidated Net Income / (Loss)	54	63	37
Net Income / (Loss) Continuing Operations	54	63	37
Total Pre-Tax Income	74	82	51
Total Operating Income	69	84	51
Total Gross Profit	215	235	190
Total Revenue	637	670	594
Operating Revenue	637	670	594
Total Cost of Revenue	422	435	404
Operating Cost of Revenue	422	435	404
Total Operating Expenses	146	151	139
Selling, General & Admin Expense	70	75	67
Marketing Expense	46	51	49
Research & Development Expense	20	22	22
Other Operating Expenses / (Income)	3.60	2.49	0.93
Impairment Charge	6.53	0.00	0.00
Total Other Income / (Expense), net	4.34	-1.81	0.01
Interest Expense	3.21	3.91	2.22
Interest & Investment Income	0.63	1.81	2.57
Other Income / (Expense), net	6.93	0.28	-0.34
Income Tax Expense	19	19	14
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.01	0.02
Basic Earnings per Share	$11.03	$12.87	$7.56
Weighted Average Basic Shares Outstanding	4.93M	4.92M	4.91M
Diluted Earnings per Share	$10.88	$12.68	$7.50
Weighted Average Diluted Shares Outstanding	5.00M	5.00M	4.95M
Weighted Average Basic & Diluted Shares Outstanding	4.92M	4.90M	4.94M
Cash Dividends to Common per Share	$0.80	$0.80	$0.80

This table shows Preformed Line Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	12	17	21	20	15	6.33	9.60	9.37	7.68	10
Consolidated Net Income / (Loss)	12	16	21	20	15	6.31	9.60	9.37	7.70	10
Net Income / (Loss) Continuing Operations	12	16	21	20	15	6.31	9.60	9.37	7.70	10
Total Pre-Tax Income	18	24	28	28	20	6.97	12	11	10	17
Total Operating Income	17	25	29	28	20	6.95	12	11	10	18
Total Gross Profit	58	62	66	66	54	48	44	44	46	56
Total Revenue	165	170	182	182	160	146	141	139	147	167
Operating Revenue	165	170	182	182	160	146	141	139	147	167
Total Cost of Revenue	107	108	116	115	106	98	97	94	101	111
Operating Cost of Revenue	107	108	116	115	106	98	97	94	101	111
Total Operating Expenses	41	38	37	38	34	41	33	33	35	38
Selling, General & Admin Expense	17	20	19	18	18	20	17	15	16	19
Marketing Expense	11	12	12	13	13	13	12	12	12	13
Research & Development Expense	4.74	4.78	5.19	5.76	5.84	5.69	5.43	5.36	5.55	5.59
Other Operating Expenses / (Income)	0.94	1.13	1.11	1.19	-2.31	2.50	-1.37	0.45	1.11	0.75
Total Other Income / (Expense), net	0.22	-0.38	-0.72	-0.61	-0.50	0.02	0.30	-0.13	0.04	-0.19
Interest Expense	0.82	1.09	1.07	1.13	1.00	0.71	0.71	0.57	0.56	0.38
Interest & Investment Income	0.14	0.27	0.30	0.42	0.48	0.61	0.97	0.35	0.54	0.72
Other Income / (Expense), net	0.90	0.43	0.04	0.11	0.02	0.12	0.04	0.09	0.06	-0.53
Income Tax Expense	5.71	7.72	6.84	7.08	4.43	0.66	2.26	1.79	2.73	6.88
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-0.02	0.02	-0.01	0.02	-0.02	0.01	0.00	0.02	-0.01
Basic Earnings per Share	$2.41	$3.35	$4.33	$4.14	$3.08	$1.32	$1.95	$1.91	$1.57	$2.13
Weighted Average Basic Shares Outstanding	4.94M	4.93M	4.94M	4.94M	4.91M	4.92M	4.92M	4.92M	4.90M	4.91M
Diluted Earnings per Share	$2.36	$3.26	$4.28	$4.08	$3.03	$1.29	$1.94	$1.89	$1.54	$2.13
Weighted Average Diluted Shares Outstanding	5.04M	5.00M	5.00M	5.02M	4.99M	5.00M	4.94M	4.96M	4.98M	4.95M
Weighted Average Basic & Diluted Shares Outstanding	4.92M	4.92M	4.95M	4.92M	4.89M	4.90M	4.92M	4.91M	4.90M	4.94M

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	0.83	16	3.64
Net Cash From Operating Activities	26	108	67
Net Cash From Continuing Operating Activities	26	108	67
Net Income / (Loss) Continuing Operations	54	63	37
Consolidated Net Income / (Loss)	54	63	37
Depreciation Expense	16	19	21
Non-Cash Adjustments To Reconcile Net Income	12	14	6.12
Changes in Operating Assets and Liabilities, net	-56	11	3.42
Net Cash From Investing Activities	-47	-45	-12
Net Cash From Continuing Investing Activities	-47	-45	-12
Purchase of Property, Plant & Equipment	-41	-35	-15
Acquisitions	-16	-12	0.00
Purchase of Investments	0.00	0.00	-3.15
Sale of Property, Plant & Equipment	3.17	2.63	3.45
Sale and/or Maturity of Investments	0.00	0.00	1.99
Other Investing Activities, net	6.91	0.00	0.00
Net Cash From Financing Activities	23	-49	-48
Net Cash From Continuing Financing Activities	23	-49	-48
Repayment of Debt	-154	-197	-132
Repurchase of Common Equity	-5.47	-19	-8.61
Payment of Dividends	-4.10	-4.11	-4.08
Issuance of Debt	185	169	96
Issuance of Common Equity	0.81	2.16	0.21
Other Net Changes in Cash	-1.11	2.44	-3.68

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	0.85	6.29	-5.45	11	0.58	9.87	-7.75	1.57	0.07	9.75
Net Cash From Operating Activities	15	17	25	20	43	19	5.75	28	9.37	24
Net Cash From Continuing Operating Activities	15	17	25	20	43	19	5.75	28	9.37	24
Net Income / (Loss) Continuing Operations	12	16	21	20	15	6.31	9.60	9.37	7.70	10
Consolidated Net Income / (Loss)	12	16	21	20	15	6.31	9.60	9.37	7.70	10
Depreciation Expense	3.31	6.24	4.28	4.69	4.64	5.31	5.41	5.25	5.32	4.85
Non-Cash Adjustments To Reconcile Net Income	7.40	5.66	3.02	3.91	0.92	6.58	-0.23	0.16	1.08	5.11
Changes in Operating Assets and Liabilities, net	-7.30	-11	-3.29	-8.64	22	1.09	-9.03	14	-4.73	3.67
Net Cash From Investing Activities	-11	-19	-22	-6.84	-7.56	-8.09	-0.68	-3.60	-3.45	-4.63
Net Cash From Continuing Investing Activities	-11	-19	-22	-6.84	-7.56	-8.09	-0.68	-3.60	-3.45	-4.63
Purchase of Property, Plant & Equipment	-11	-15	-8.35	-8.83	-9.94	-8.21	-3.92	-3.73	-3.57	-3.43
Sale of Property, Plant & Equipment	-	0.01	0.12	0.01	2.38	0.13	3.24	0.13	0.13	-0.04
Net Cash From Financing Activities	-0.88	7.90	-9.31	-2.36	-34	-3.38	-12	-22	-7.30	-7.00
Net Cash From Continuing Financing Activities	-0.88	7.90	-9.31	-2.36	-34	-3.38	-12	-22	-7.30	-7.00
Repayment of Debt	-41	-48	-55	-49	-46	-46	-33	-45	-45	-8.11
Repurchase of Common Equity	-2.14	-1.53	-3.74	-6.10	-8.56	-0.49	-5.45	-0.57	-2.23	-0.35
Payment of Dividends	-1.02	-1.01	-1.15	-0.99	-0.98	-0.98	-1.13	-0.98	-0.98	-0.98
Issuance of Debt	43	58	50	54	21	44	28	25	41	2.39
Issuance of Common Equity	0.36	0.33	0.36	0.31	1.36	0.14	0.06	0.00	0.10	0.05
Other Net Changes in Cash	-	-	-	-	-	-	-1.15	-	-	-2.69

This table presents Preformed Line Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	568	603	574
Total Current Assets	328	325	316
Restricted Cash	37	54	57
Accounts Receivable	125	107	111
Inventories, net	147	149	130
Prepaid Expenses	13	8.25	12
Other Current Assets	4.93	7.26	5.51
Plant, Property, & Equipment, net	175	208	195
Total Noncurrent Assets	65	70	63
Goodwill	28	29	27
Intangible Assets	14	13	9.66
Noncurrent Deferred & Refundable Income Taxes	5.32	7.11	6.55
Other Noncurrent Operating Assets	18	21	20
Total Liabilities & Shareholders' Equity	568	603	574
Total Liabilities	210	187	152
Total Current Liabilities	115	111	108
Short-Term Debt	21	13	10
Accounts Payable	47	38	42
Accrued Expenses	18	27	26
Dividends Payable	1.32	1.30	1.29
Current Deferred & Payable Income Tax Liabilities	2.47	1.67	1.96
Current Employee Benefit Liabilities	24	28	26
Other Current Liabilities	1.61	1.67	1.59
Total Noncurrent Liabilities	95	76	43
Long-Term Debt	68	49	18
Noncurrent Deferred & Payable Income Tax Liabilities	4.17	3.54	3.77
Other Noncurrent Operating Liabilities	22	23	21
Total Equity & Noncontrolling Interests	359	416	422
Total Preferred & Common Equity	359	416	422
Total Common Equity	359	416	422
Common Stock	67	75	79
Retained Earnings	461	520	553
Treasury Stock	-99	-118	-127
Accumulated Other Comprehensive Income / (Loss)	-70	-60	-83
Other Equity Adjustments	0.00	0.00	0.00
Noncontrolling Interest	-0.01	-0.01	0.01

This table presents Preformed Line Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	531	602	622	607	586	573	592
Total Current Assets	308	339	353	338	314	305	321
Restricted Cash	-	32	43	44	46	-	47
Accounts Receivable	123	141	145	126	112	101	111
Inventories, net	135	150	148	150	142	142	143
Prepaid Expenses	-	8.30	8.75	8.33	8.31	7.39	13
Other Current Assets	3.25	8.18	8.44	10	7.05	6.98	6.48
Plant, Property, & Equipment, net	160	196	200	201	203	200	201
Total Noncurrent Assets	63	67	68	67	69	67	70
Goodwill	26	29	30	28	29	28	29
Intangible Assets	14	14	14	13	12	11	11
Noncurrent Deferred & Refundable Income Taxes	5.90	6.15	6.42	6.93	7.38	7.72	9.50
Other Noncurrent Operating Assets	17	17	18	19	21	20	21
Total Liabilities & Shareholders' Equity	531	602	622	607	586	573	592
Total Liabilities	200	222	223	207	173	156	163
Total Current Liabilities	120	125	127	136	100	104	114
Short-Term Debt	21	17	21	18	8.57	9.75	11
Accounts Payable	48	56	50	51	42	43	42
Accrued Expenses	18	19	23	27	21	23	26
Dividends Payable	1.28	1.19	1.23	1.26	1.19	1.22	1.26
Current Deferred & Payable Income Tax Liabilities	2.36	7.80	5.79	6.76	2.36	1.53	2.35
Current Employee Benefit Liabilities	28	22	25	30	23	24	29
Other Current Liabilities	1.64	1.54	1.19	1.63	1.53	1.56	1.61
Total Noncurrent Liabilities	79	96	97	71	73	52	49
Long-Term Debt	56	68	69	45	48	29	25
Capital Lease Obligations	6.33	7.11	-	7.91	7.39	-	6.99
Noncurrent Deferred & Payable Income Tax Liabilities	3.86	3.51	3.31	2.98	3.41	2.21	2.84
Other Noncurrent Operating Liabilities	13	17	24	15	14	21	15
Total Equity & Noncontrolling Interests	331	381	398	400	413	416	429
Total Preferred & Common Equity	331	381	398	400	413	416	429
Total Common Equity	331	381	398	400	413	416	429
Common Stock	65	68	70	73	75	76	77
Retained Earnings	445	481	501	515	529	537	544
Treasury Stock	-98	-103	-109	-118	-124	-124	-127
Accumulated Other Comprehensive Income / (Loss)	-82	-66	-64	-70	-67	-73	-65
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	0.01	0.01	0.00	0.02	-0.00	0.00	0.02

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	23.12%	5.13%	-11.34%
EBITDA Growth	39.82%	11.47%	-31.06%
EBIT Growth	50.32%	10.68%	-40.29%
NOPAT Growth	47.37%	26.44%	-42.68%
Net Income Growth	52.29%	16.43%	-41.41%
EPS Growth	51.32%	16.54%	-40.85%
Operating Cash Flow Growth	-22.16%	311.59%	-37.31%
Free Cash Flow Firm Growth	-1,116.58%	348.59%	34.18%
Invested Capital Growth	21.04%	3.36%	-7.31%
Revenue Q/Q Growth	6.43%	-3.50%	3.76%
EBITDA Q/Q Growth	17.54%	-15.45%	15.30%
EBIT Q/Q Growth	19.78%	-17.53%	24.50%
NOPAT Q/Q Growth	20.47%	-13.87%	13.15%
Net Income Q/Q Growth	16.09%	-13.85%	12.54%
EPS Q/Q Growth	15.62%	-13.45%	12.61%
Operating Cash Flow Q/Q Growth	40.35%	2.14%	7.62%
Free Cash Flow Firm Q/Q Growth	-182.29%	60.18%	89.88%
Invested Capital Q/Q Growth	7.16%	-0.47%	-7.06%
Profitability Metrics	-	-	-
Gross Margin	33.78%	35.07%	31.97%
EBITDA Margin	14.55%	15.43%	12.00%
Operating Margin	10.89%	12.57%	8.55%
EBIT Margin	11.98%	12.61%	8.49%
Profit (Net Income) Margin	8.54%	9.46%	6.25%
Tax Burden Percent	73.81%	76.92%	73.10%
Interest Burden Percent	96.61%	97.52%	100.70%
Effective Tax Rate	26.19%	23.08%	26.90%
Return on Invested Capital (ROIC)	13.60%	15.44%	9.04%
ROIC Less NNEP Spread (ROIC-NNEP)	21.81%	11.06%	8.93%
Return on Net Nonoperating Assets (RNNOA)	2.52%	0.91%	-0.19%
Return on Equity (ROE)	16.12%	16.35%	8.85%
Cash Return on Invested Capital (CROIC)	-5.44%	12.14%	16.63%
Operating Return on Assets (OROA)	14.43%	14.41%	8.57%
Return on Assets (ROA)	10.29%	10.81%	6.31%
Return on Common Equity (ROCE)	16.13%	16.35%	8.85%
Return on Equity Simple (ROE_SIMPLE)	15.17%	15.22%	8.79%
Net Operating Profit after Tax (NOPAT)	51	65	37
NOPAT Margin	8.04%	9.67%	6.25%
Net Nonoperating Expense Percent (NNEP)	-8.21%	4.38%	0.11%
Return On Investment Capital (ROIC_SIMPLE)	11.42%	13.53%	8.23%
Cost of Revenue to Revenue	66.22%	64.93%	68.03%
SG&A Expenses to Revenue	11.04%	11.15%	11.37%
R&D to Revenue	3.09%	3.36%	3.69%
Operating Expenses to Revenue	22.89%	22.50%	23.42%
Earnings before Interest and Taxes (EBIT)	76	84	50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	93	103	71
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.13	1.56	1.48
Price to Tangible Book Value (P/TBV)	1.28	1.74	1.62
Price to Revenue (P/Rev)	0.63	0.97	1.05
Price to Earnings (P/E)	7.43	10.26	16.85
Dividend Yield	0.97%	0.60%	0.63%
Earnings Yield	13.47%	9.74%	5.94%
Enterprise Value to Invested Capital (EV/IC)	1.11	1.55	1.51
Enterprise Value to Revenue (EV/Rev)	0.72	0.98	1.00
Enterprise Value to EBITDA (EV/EBITDA)	4.92	6.37	8.37
Enterprise Value to EBIT (EV/EBIT)	5.98	7.80	11.83
Enterprise Value to NOPAT (EV/NOPAT)	8.91	10.17	16.07
Enterprise Value to Operating Cash Flow (EV/OCF)	17.44	6.12	8.84
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	12.95	8.73
Leverage & Solvency	-	-	-
Debt to Equity	0.25	0.15	0.07
Long-Term Debt to Equity	0.19	0.12	0.04
Financial Leverage	0.12	0.08	-0.02
Leverage Ratio	1.57	1.51	1.40
Compound Leverage Factor	1.51	1.47	1.41
Debt to Total Capital	19.98%	13.01%	6.34%
Short-Term Debt to Total Capital	4.71%	2.81%	2.26%
Long-Term Debt to Total Capital	15.27%	10.20%	4.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	80.02%	86.99%	93.66%
Debt to EBITDA	0.97	0.60	0.40
Net Debt to EBITDA	0.56	0.08	-0.40
Long-Term Debt to EBITDA	0.74	0.47	0.26
Debt to NOPAT	1.75	0.96	0.77
Net Debt to NOPAT	1.02	0.13	-0.77
Long-Term Debt to NOPAT	1.34	0.75	0.49
Altman Z-Score	4.30	5.29	5.58
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.85	2.92	2.91
Quick Ratio	1.09	0.96	1.03
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-20	51	68
Operating Cash Flow to CapEx	69.87%	329.17%	602.66%
Free Cash Flow to Firm to Interest Expense	-6.37	13.03	30.73
Operating Cash Flow to Interest Expense	8.14	27.57	30.38
Operating Cash Flow Less CapEx to Interest Expense	-3.51	19.19	25.34
Efficiency Ratios	-	-	-
Asset Turnover	1.20	1.14	1.01
Accounts Receivable Turnover	5.70	5.77	5.44
Inventory Turnover	3.22	2.94	2.90
Fixed Asset Turnover	3.92	3.50	2.95
Accounts Payable Turnover	9.46	10.28	10.13
Days Sales Outstanding (DSO)	64.02	63.27	67.10
Days Inventory Outstanding (DIO)	113.33	124.35	125.94
Days Payable Outstanding (DPO)	38.60	35.52	36.03
Cash Conversion Cycle (CCC)	138.76	152.09	157.01
Capital & Investment Metrics	-	-	-
Invested Capital	412	426	395
Invested Capital Turnover	1.69	1.60	1.45
Increase / (Decrease) in Invested Capital	72	14	-31
Enterprise Value (EV)	456	659	596
Market Capitalization	404	650	625
Book Value per Share	$72.90	$85.04	$86.23
Tangible Book Value per Share	$64.34	$76.36	$78.81
Total Capital	448	478	451
Total Debt	90	62	29
Total Long-Term Debt	68	49	18
Net Debt	52	8.64	-29
Capital Expenditures (CapEx)	37	33	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	197	173	160
Debt-free Net Working Capital (DFNWC)	234	227	218
Net Working Capital (NWC)	213	213	207
Net Nonoperating Expense (NNE)	-3.21	1.39	-0.01
Net Nonoperating Obligations (NNO)	54	9.94	-27
Total Depreciation and Amortization (D&A)	16	19	21
Debt-free, Cash-free Net Working Capital to Revenue	30.88%	25.88%	27.01%
Debt-free Net Working Capital to Revenue	36.73%	33.89%	36.65%
Net Working Capital to Revenue	33.41%	31.88%	34.93%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$11.03	$12.87	$7.56
Adjusted Weighted Average Basic Shares Outstanding	4.93M	4.92M	4.91M
Adjusted Diluted Earnings per Share	$10.88	$12.68	$7.50
Adjusted Weighted Average Diluted Shares Outstanding	5.00M	5.00M	4.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.92M	4.90M	4.94M
Normalized Net Operating Profit after Tax (NOPAT)	56	65	37
Normalized NOPAT Margin	8.79%	9.67%	6.25%
Pre Tax Income Margin	11.57%	12.30%	8.55%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	23.74	21.62	22.70
NOPAT to Interest Expense	15.93	16.58	16.70
EBIT Less CapEx to Interest Expense	12.09	13.25	17.66
NOPAT Less CapEx to Interest Expense	4.28	8.20	11.66
Payout Ratios	-	-	-
Dividend Payout Ratio	7.54%	6.48%	10.98%
Augmented Payout Ratio	17.58%	36.31%	34.17%

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	22.18%	29.27%	31.54%	11.22%	-3.00%	-14.31%	-22.51%	-23.70%	-8.39%	14.78%
EBITDA Growth	19.58%	79.38%	89.45%	47.76%	14.58%	-60.41%	-48.92%	-49.53%	-36.21%	76.40%
EBIT Growth	27.52%	101.47%	99.40%	53.20%	9.98%	-71.76%	-60.05%	-59.71%	-47.97%	140.41%
NOPAT Growth	15.73%	104.21%	167.19%	50.86%	32.32%	-62.45%	-57.39%	-54.69%	-50.64%	67.91%
Net Income Growth	11.08%	84.22%	74.12%	49.14%	27.39%	-61.74%	-55.17%	-54.23%	-49.18%	65.56%
EPS Growth	9.77%	82.12%	71.89%	47.29%	28.39%	-60.43%	-54.67%	-53.68%	-49.17%	65.12%
Operating Cash Flow Growth	52.61%	79.05%	591.40%	2,137.92%	177.82%	13.25%	-77.38%	38.56%	-77.96%	24.78%
Free Cash Flow Firm Growth	-120.49%	-94.59%	30.16%	-33.85%	26.69%	86.21%	149.08%	207.32%	138.86%	651.10%
Invested Capital Growth	14.85%	21.04%	16.05%	16.95%	11.28%	3.36%	-2.23%	-8.40%	-0.74%	-7.31%
Revenue Q/Q Growth	1.18%	2.73%	7.00%	-0.01%	-11.76%	-9.25%	-3.23%	-1.55%	5.95%	13.71%
EBITDA Q/Q Growth	-3.19%	44.81%	6.52%	-1.05%	-24.92%	-49.96%	37.42%	-2.23%	-5.12%	38.38%
EBIT Q/Q Growth	-0.93%	36.91%	16.01%	-2.64%	-28.88%	-64.84%	64.10%	-1.82%	-8.14%	62.44%
NOPAT Q/Q Growth	-15.33%	42.68%	31.14%	-4.79%	-25.73%	-59.51%	48.82%	1.24%	-19.09%	37.73%
Net Income Q/Q Growth	-13.35%	38.68%	29.91%	-4.46%	-25.99%	-58.34%	52.21%	-2.46%	-17.84%	35.72%
EPS Q/Q Growth	-14.80%	38.14%	31.29%	-4.67%	-25.74%	-57.43%	50.39%	-2.58%	-18.52%	38.31%
Operating Cash Flow Q/Q Growth	1,626.85%	11.32%	49.32%	-19.70%	108.15%	-54.62%	-70.17%	391.81%	-66.90%	156.96%
Free Cash Flow Firm Q/Q Growth	-16.30%	-44.47%	28.58%	-11.54%	36.30%	72.83%	354.24%	143.90%	-76.93%	285.32%
Invested Capital Q/Q Growth	0.87%	7.16%	7.33%	0.81%	-4.02%	-0.47%	1.52%	-5.55%	4.00%	-7.06%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.24%	36.62%	36.45%	36.48%	33.74%	33.04%	31.32%	31.92%	31.15%	33.29%
EBITDA Margin	13.05%	18.40%	18.31%	18.12%	15.42%	8.50%	12.07%	11.99%	10.74%	13.06%
Operating Margin	10.50%	14.47%	15.94%	15.48%	12.51%	4.77%	8.20%	8.14%	7.07%	10.48%
EBIT Margin	11.05%	14.72%	15.96%	15.54%	12.53%	4.85%	8.23%	8.21%	7.11%	10.16%
Profit (Net Income) Margin	7.19%	9.70%	11.78%	11.26%	9.44%	4.33%	6.82%	6.75%	5.24%	6.25%
Tax Burden Percent	67.57%	68.12%	75.80%	74.30%	77.37%	90.54%	80.98%	83.93%	73.79%	60.30%
Interest Burden Percent	96.30%	96.75%	97.37%	97.47%	97.41%	98.63%	102.28%	98.05%	99.75%	101.98%
Effective Tax Rate	32.43%	31.88%	24.20%	25.70%	22.63%	9.46%	19.02%	16.07%	26.21%	39.70%
Return on Invested Capital (ROIC)	11.81%	16.68%	19.96%	19.43%	16.53%	6.90%	9.55%	9.36%	7.00%	9.14%
ROIC Less NNEP Spread (ROIC-NNEP)	12.18%	16.01%	19.00%	18.50%	15.59%	6.96%	10.15%	8.81%	7.23%	10.47%
Return on Net Nonoperating Assets (RNNOA)	1.52%	1.85%	3.06%	2.44%	1.75%	0.57%	1.03%	0.43%	0.21%	-0.22%
Return on Equity (ROE)	13.33%	18.54%	23.02%	21.87%	18.28%	7.47%	10.58%	9.80%	7.21%	8.92%
Cash Return on Invested Capital (CROIC)	-2.01%	-5.44%	0.76%	1.61%	7.81%	12.14%	14.18%	18.29%	8.43%	16.63%
Operating Return on Assets (OROA)	12.91%	17.74%	19.11%	18.75%	15.29%	5.55%	8.71%	8.05%	6.79%	10.25%
Return on Assets (ROA)	8.40%	11.69%	14.11%	13.58%	11.52%	4.95%	7.21%	6.62%	5.00%	6.31%
Return on Common Equity (ROCE)	13.33%	18.54%	23.02%	21.87%	18.28%	7.47%	10.58%	9.80%	7.21%	8.92%
Return on Equity Simple (ROE_SIMPLE)	14.16%	0.00%	16.68%	17.63%	18.39%	0.00%	12.46%	9.71%	7.69%	0.00%
Net Operating Profit after Tax (NOPAT)	12	17	22	21	16	6.29	9.36	9.48	7.67	11
NOPAT Margin	7.10%	9.86%	12.08%	11.50%	9.68%	4.32%	6.64%	6.83%	5.22%	6.32%
Net Nonoperating Expense Percent (NNEP)	-0.38%	0.67%	0.96%	0.94%	0.95%	-0.06%	-0.60%	0.55%	-0.23%	-1.33%
Return On Investment Capital (ROIC_SIMPLE)	-	3.74%	-	-	-	1.31%	-	-	-	2.34%
Cost of Revenue to Revenue	64.76%	63.38%	63.55%	63.52%	66.26%	66.96%	68.68%	68.08%	68.85%	66.71%
SG&A Expenses to Revenue	10.56%	11.53%	10.23%	10.02%	11.09%	13.75%	11.79%	10.99%	11.17%	11.49%
R&D to Revenue	2.87%	2.81%	2.86%	3.17%	3.64%	3.91%	3.85%	3.86%	3.77%	3.34%
Operating Expenses to Revenue	24.74%	22.15%	20.52%	21.00%	21.23%	28.26%	23.12%	23.78%	24.08%	22.81%
Earnings before Interest and Taxes (EBIT)	18	25	29	28	20	7.07	12	11	10	17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22	31	33	33	25	12	17	17	16	22
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.05	1.13	1.64	1.93	1.99	1.56	1.52	1.47	1.46	1.48
Price to Tangible Book Value (P/TBV)	1.19	1.28	1.85	2.16	2.21	1.74	1.69	1.62	1.61	1.62
Price to Revenue (P/Rev)	0.58	0.63	0.92	1.10	1.14	0.97	1.00	1.04	1.10	1.05
Price to Earnings (P/E)	7.42	7.43	9.85	10.93	10.80	10.26	12.21	15.13	19.06	16.85
Dividend Yield	1.14%	0.97%	0.63%	0.52%	0.50%	0.60%	0.62%	0.64%	0.63%	0.63%
Earnings Yield	13.48%	13.47%	10.16%	9.15%	9.26%	9.74%	8.19%	6.61%	5.25%	5.94%
Enterprise Value to Invested Capital (EV/IC)	1.04	1.11	1.55	1.83	1.92	1.55	1.50	1.48	1.47	1.51
Enterprise Value to Revenue (EV/Rev)	0.67	0.72	1.01	1.16	1.18	0.98	1.03	1.03	1.09	1.00
Enterprise Value to EBITDA (EV/EBITDA)	5.07	4.92	6.33	6.84	6.72	6.37	7.43	8.52	10.08	8.37
Enterprise Value to EBIT (EV/EBIT)	6.28	5.98	7.56	8.10	8.02	7.80	9.66	12.02	15.39	11.83
Enterprise Value to NOPAT (EV/NOPAT)	9.41	8.91	10.67	11.41	10.93	10.17	12.41	14.81	19.00	16.07
Enterprise Value to Operating Cash Flow (EV/OCF)	21.47	17.44	12.08	10.41	7.79	6.12	7.36	6.29	9.94	8.84
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	220.54	121.90	25.86	12.95	10.43	7.71	17.33	8.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.25	0.25	0.24	0.22	0.18	0.15	0.15	0.09	0.10	0.07
Long-Term Debt to Equity	0.19	0.19	0.20	0.17	0.13	0.12	0.13	0.07	0.07	0.04
Financial Leverage	0.12	0.12	0.16	0.13	0.11	0.08	0.10	0.05	0.03	-0.02
Leverage Ratio	1.60	1.57	1.60	1.59	1.56	1.51	1.50	1.47	1.45	1.40
Compound Leverage Factor	1.54	1.52	1.56	1.55	1.52	1.49	1.53	1.44	1.44	1.43
Debt to Total Capital	20.12%	19.98%	19.52%	18.35%	15.03%	13.01%	13.39%	8.48%	8.96%	6.34%
Short-Term Debt to Total Capital	5.09%	4.71%	3.57%	4.22%	3.73%	2.81%	1.79%	2.14%	2.25%	2.26%
Long-Term Debt to Total Capital	15.03%	15.27%	15.96%	14.13%	11.30%	10.20%	11.59%	6.34%	6.70%	4.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	79.88%	80.02%	80.48%	81.65%	84.96%	86.99%	86.61%	91.52%	91.04%	93.66%
Debt to EBITDA	1.06	0.97	0.85	0.75	0.58	0.60	0.73	0.55	0.68	0.40
Net Debt to EBITDA	0.66	0.56	0.56	0.39	0.22	0.08	0.21	-0.13	-0.09	-0.40
Long-Term Debt to EBITDA	0.79	0.74	0.70	0.58	0.44	0.47	0.64	0.41	0.51	0.26
Debt to NOPAT	1.96	1.75	1.44	1.26	0.94	0.96	1.23	0.95	1.29	0.77
Net Debt to NOPAT	1.23	1.02	0.94	0.65	0.36	0.13	0.35	-0.22	-0.16	-0.77
Long-Term Debt to NOPAT	1.47	1.34	1.17	0.97	0.71	0.75	1.06	0.71	0.96	0.49
Altman Z-Score	3.89	4.01	4.53	4.90	5.15	4.87	5.03	5.17	5.04	5.39
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.56	2.85	2.71	2.79	2.49	2.92	3.15	2.93	2.81	2.91
Quick Ratio	1.28	1.09	1.13	1.14	0.93	0.96	1.12	1.43	0.97	1.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-38	-55	-39	-44	-28	-7.57	19	47	11	42
Operating Cash Flow to CapEx	134.60%	110.51%	309.10%	231.49%	561.92%	238.45%	844.79%	785.94%	271.79%	693.57%
Free Cash Flow to Firm to Interest Expense	-46.40	-50.61	-36.79	-38.57	-27.92	-10.71	27.18	82.64	19.20	109.50
Operating Cash Flow to Interest Expense	18.68	15.70	23.86	18.01	42.59	27.28	8.13	49.81	16.61	63.17
Operating Cash Flow Less CapEx to Interest Expense	4.80	1.49	16.14	10.23	35.01	15.84	7.16	43.48	10.50	54.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.17	1.20	1.20	1.21	1.22	1.14	1.06	0.98	0.95	1.01
Accounts Receivable Turnover	5.18	5.70	5.30	5.22	5.58	5.77	4.98	4.76	4.83	5.44
Inventory Turnover	3.34	3.22	3.20	3.23	3.13	2.94	2.86	2.72	2.67	2.90
Fixed Asset Turnover	3.89	3.92	3.86	3.91	3.85	3.50	3.15	2.92	2.84	2.95
Accounts Payable Turnover	9.37	9.46	8.19	8.98	8.94	10.28	8.49	8.50	8.31	10.13
Days Sales Outstanding (DSO)	70.42	64.02	68.88	69.90	65.47	63.27	73.33	76.67	75.56	67.10
Days Inventory Outstanding (DIO)	109.38	113.33	114.15	112.93	116.56	124.35	127.77	134.11	136.84	125.94
Days Payable Outstanding (DPO)	38.96	38.60	44.59	40.63	40.83	35.52	43.00	42.96	43.94	36.03
Cash Conversion Cycle (CCC)	140.84	138.76	138.44	142.21	141.19	152.09	158.11	167.83	168.46	157.01
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	385	412	442	446	428	426	433	409	425	395
Invested Capital Turnover	1.66	1.69	1.65	1.69	1.71	1.60	1.44	1.37	1.34	1.45
Increase / (Decrease) in Invested Capital	50	72	61	65	43	14	-9.89	-37	-3.16	-31
Enterprise Value (EV)	400	456	686	814	821	659	647	603	623	596
Market Capitalization	348	404	625	768	794	650	629	612	628	625
Book Value per Share	$67.00	$72.90	$77.39	$80.52	$81.34	$85.04	$84.29	$84.63	$87.30	$86.23
Tangible Book Value per Share	$58.89	$64.34	$68.73	$71.79	$72.96	$76.36	$76.04	$76.71	$79.23	$78.81
Total Capital	414	448	473	488	471	478	477	455	471	451
Total Debt	83	90	92	90	71	62	64	39	42	29
Total Long-Term Debt	62	68	75	69	53	49	55	29	32	18
Net Debt	52	52	61	46	27	8.64	18	-8.85	-5.30	-29
Capital Expenditures (CapEx)	11	15	8.23	8.82	7.56	8.09	0.68	3.60	3.45	3.47
Debt-free, Cash-free Net Working Capital (DFCFNWC)	178	197	199	204	176	173	177	163	170	160
Debt-free Net Working Capital (DFNWC)	209	234	231	247	220	227	223	211	217	218
Net Working Capital (NWC)	188	213	214	227	202	213	215	201	207	207
Net Nonoperating Expense (NNE)	-0.15	0.26	0.55	0.45	0.39	-0.02	-0.24	0.11	-0.03	0.12
Net Nonoperating Obligations (NNO)	54	54	62	48	28	9.94	19	-7.63	-4.04	-27
Total Depreciation and Amortization (D&A)	3.31	6.24	4.28	4.69	4.64	5.31	5.41	5.25	5.32	4.85
Debt-free, Cash-free Net Working Capital to Revenue	29.71%	30.88%	29.24%	29.20%	25.39%	25.88%	28.19%	27.90%	29.67%	27.01%
Debt-free Net Working Capital to Revenue	34.89%	36.73%	33.91%	35.37%	31.69%	33.89%	35.49%	36.00%	37.97%	36.65%
Net Working Capital to Revenue	31.36%	33.41%	31.43%	32.43%	29.16%	31.88%	34.12%	34.34%	36.11%	34.93%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.41	$3.35	$4.33	$4.14	$3.08	$1.32	$1.95	$1.91	$1.57	$2.13
Adjusted Weighted Average Basic Shares Outstanding	4.94M	4.93M	4.94M	4.94M	4.91M	4.92M	4.92M	4.92M	4.90M	4.91M
Adjusted Diluted Earnings per Share	$2.36	$3.26	$4.28	$4.08	$3.03	$1.29	$1.94	$1.89	$1.54	$2.13
Adjusted Weighted Average Diluted Shares Outstanding	5.04M	5.00M	5.00M	5.02M	4.99M	5.00M	4.94M	4.96M	4.98M	4.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.92M	4.92M	4.95M	4.92M	4.89M	4.90M	4.92M	4.91M	4.90M	4.94M
Normalized Net Operating Profit after Tax (NOPAT)	16	17	22	21	16	6.29	9.36	9.48	7.67	11
Normalized NOPAT Margin	9.76%	9.86%	12.08%	11.50%	9.68%	4.32%	6.64%	6.83%	5.22%	6.32%
Pre Tax Income Margin	10.64%	14.24%	15.54%	15.15%	12.20%	4.79%	8.42%	8.05%	7.10%	10.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	22.31	23.06	27.22	24.92	20.14	9.99	16.38	20.04	18.54	44.58
NOPAT to Interest Expense	14.33	15.44	20.61	18.44	15.56	8.90	13.22	16.68	13.60	27.72
EBIT Less CapEx to Interest Expense	8.43	8.85	19.51	17.14	12.56	-1.45	15.41	13.70	12.43	35.47
NOPAT Less CapEx to Interest Expense	0.46	1.23	12.89	10.66	7.99	-2.54	12.26	10.35	7.49	18.61
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.79%	7.54%	6.65%	5.95%	5.63%	6.48%	7.92%	10.09%	12.36%	10.98%
Augmented Payout Ratio	17.19%	17.58%	18.32%	25.18%	32.74%	36.31%	47.91%	47.37%	38.89%	34.17%

Frequently Asked Questions About Preformed Line Products' Financials

When does Preformed Line Products's financial year end?

According to the most recent income statement we have on file, Preformed Line Products' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Preformed Line Products' net income changed over the last 2 years?

Preformed Line Products' net income appears to be on a downward trend, with a most recent value of $37.11 million in 2024, falling from $54.40 million in 2022. The previous period was $63.34 million in 2023.

What is Preformed Line Products's operating income?

Preformed Line Products's total operating income in 2024 was $50.76 million, based on the following breakdown:

Total Gross Profit: $189.81 million
Total Operating Expenses: $139.05 million

How has Preformed Line Products revenue changed over the last 2 years?

Over the last 2 years, Preformed Line Products' total revenue changed from $637.02 million in 2022 to $593.71 million in 2024, a change of -6.8%.

How much debt does Preformed Line Products have?

Preformed Line Products' total liabilities were at $151.55 million at the end of 2024, a 19.0% decrease from 2023, and a 27.8% decrease since 2022.

How has Preformed Line Products' book value per share changed over the last 2 years?

Over the last 2 years, Preformed Line Products' book value per share changed from 72.90 in 2022 to 86.23 in 2024, a change of 18.3%.

Related Companies

This page (NASDAQ:PLPC) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Preformed Line Products (PLPC) Financials

Frequently Asked Questions About Preformed Line Products' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Preformed Line Products (PLPC) Financials

Annual Income Statements for Preformed Line Products

Quarterly Income Statements for Preformed Line Products

Annual Cash Flow Statements for Preformed Line Products

Quarterly Cash Flow Statements for Preformed Line Products

Annual Balance Sheets for Preformed Line Products

Quarterly Balance Sheets for Preformed Line Products

Annual Metrics and Ratios for Preformed Line Products

Quarterly Metrics and Ratios for Preformed Line Products

Frequently Asked Questions About Preformed Line Products' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools